Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Mathers Edward T Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 4 Mathers Edward T (10% Owner) has filed a Form 4 on Bright Health Group Inc.
Txns: Bought 828,395 warrants @ $0.01, valued at $8.3k
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2023 4 Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $2.27, valued at $68.1k
06/08/2023 4 Mathers Edward T (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.
Txns: Granted 17,500 options to buy @ $9.01, valued at $157.7k
03/06/2023 4 Mathers Edward T (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Acquired 5,771 shares @ $0
01/03/2023 3 Mathers Edward T (Director) has filed a Form 3 on ObsEva SA
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/14/2022 4 Mathers Edward T (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 9,367 options to buy @ $4.38, valued at $41k
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Mathers Edward T (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Granted 20,000 options to buy @ $4.15, valued at $83k
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Mathers Edward T (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.
Txns: Granted 17,500 options to buy @ $2.09, valued at $36.6k
04/13/2022 4 Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 948,948 shares @ $1.9, valued at $1.8M
Granted 3,000,000 options to buy @ $0.001, valued at $3k
01/05/2022 3 Mathers Edward T (10% Owner) has filed a Form 3 on Bright Health Group Inc.
06/30/2021 4 Mathers Edward T (10% Owner) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Converted 2,715,968 shares @ $0
Converted 3,257,328 shares @ $0
Converted 669,002 shares @ $0
Bought 1,050,000 shares @ $19, valued at $20M
Converted 9,588,725 convertible preferred @ $0
Converted 11,500,000 convertible preferred @ $0
Converted 2,361,912 convertible preferred @ $0
06/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2021 4/A Mathers Edward T (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Granted 15,000 options to buy @ $18.99, valued at $284.9k
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2021 4 Mathers Edward T (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Granted 15,000 options to buy @ $18.99, valued at $284.9k
06/08/2021 4 Mathers Edward T (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 17,000 options to buy @ $16.88, valued at $287k
04/12/2021 4 Mathers Edward T (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.
Txns: Granted 14,000 options to buy @ $15, valued at $210k
04/08/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
03/16/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
07/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy